PMA device
Navistar Thermocool
Biosense Webster, Inc. · Cardiac Ablation Percutaneous Catheter (LPB, Class III) · First FDA decision Dec 4, 2006, newest Aug 1, 2014Atrial fibrillation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
9
PMA pathway
Device trials
16
Naming "Navistar Thermocool"
MAUDE reports
82
Brand "Navistar Thermocool", since 2015
PubMed studies
0
Mentioning "Navistar Thermocool"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Navistar Thermocool
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 9 decisions filed under this name.
- NAVISTAR THERMOCOOLPMA supplement
P040036-S043 · Decided Aug 1, 2014 · 70 days after receipt · Normal 180 Day Track No User Fee
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
- NAVISTAR THERMOCOOL, NAVISTAR RMT THERMOCOOL, EZ STEER THERMOCOOL, EZ STEER THERMOCOOL NAV CATHETERSPMA supplement
P040036-S031 · Decided Apr 12, 2013 · 297 days after receipt · Normal 180 Day Track
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
- NAVISTAR THERMOCOOLPMA supplement
P040036-S021 · Decided Oct 1, 2010 · 213 days after receipt · Normal 180 Day Track No User Fee
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
3 more FDA decisions with a free account
Older decisions: P030031-S031, P030031-S014, P030031-S006
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Navistar Thermocool", any status and sponsor, newest update first.
Biosense Webster, Inc.Public (JNJ)
NCT00721149 · 10 participants · Start Sep 2008 · Primary completion Dec 2009
Device: Radiofrequency Ablation · For: Heart Diseases; Arrhythmia; Atrial Fibrillation
- nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial FibrillationPivotal-lookingTerminated
Biosense Webster, Inc.Public (JNJ)
NCT01824394 · 481 participants · Start Apr 1, 2013 · Primary completion Nov 26, 2017
Device: nMARQ Navigation Catheters; NaviStar ThermoCool Catheters · For: Atrial Fibrillation
- CACAF2 Study: Catheter Ablation for Cure of Atrial FibrillationPivotal-lookingTerminated
Biosense Webster EMEAPublic (JNJ)
NCT00227344 · 129 participants · Start Dec 2004 · Primary completion Oct 2008
Device: RF ablation · For: Atrial Fibrillation
13 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Navistar Thermocool", and for the whole product code for context.
This brand
82 reports: 34 malfunction, 44 injury, 4 death
Whole product code LPB
14,593 reports: 5,424 malfunction, 8,535 injury, 628 death
Newest reports for this brand
- NaviStar ThermoCoolMalfunction
3013300026-2026-03509 · Received Oct 22, 2026 · Event dated Sep 24, 2026
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Device problem as coded: Material Protrusion/Extrusion; Positioning Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- NaviStar ThermoCoolMalfunction
3013300026-2026-03514 · Received Oct 22, 2026 · Event dated Sep 4, 2026
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Device problem as coded: Obstruction of Flow
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- NaviStar ThermoCoolMalfunction
3013300026-2026-03455 · Received Oct 19, 2026 · Event dated Sep 21, 2026
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Device problem as coded: Signal Artifact/Noise; Break
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Johnson & Johnson Surgical Vision, Inc.
Z-0169-2023 · Started Sep 7, 2022 · Posted by FDA Nov 2, 2022
Reason given: Manufacturing error resulted in potential contamination of Bi-Directional navigation catheter irrigation path with cellulose fibers that can cause 1) Failure of initial flushing inspection, 2) Insufficient irrigation causing catheter tip temperature increase, limiting the ability to deliver ablation, or 3) particles...
Cause as FDA categorized it: Process control · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Z-0139-2015 · Started Oct 19, 2014 · Posted by FDA Oct 27, 2014
Reason given: The recall was initiated because Biosense Webster is providing additional labeling for the safe and effective use of the ThermoCool SmartTouch Catheter.
Cause as FDA categorized it: Use error · Device type: Cardiac Ablation Percutaneous Catheter (LPB)
Z-0979-2012 · Started Nov 22, 2010 · Posted by FDA Feb 7, 2012
Reason given: Biosense Webster, Inc. has recently become aware of the omission of the following two Warning and Precaution statements on the Instructions For Use (IFU) for the above catheter: 1. If phrenic nerve location is a concern, precautionary measures are recommended to evaluate the proximity of the nerve to the ablation...
Cause as FDA categorized it: Labeling design · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
5 more recall records with a free account
Published research
The most relevant PubMed records for "Navistar Thermocool"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LPB.
- Therapy Ablation Catheter (4mm and 8mm)Irvine Biomedical, Inc. · PMA 2022
- EZ Steer ThermoCool CatheterBiosense Webster, Inc. · PMA 2021
- Chilli II Cooled Ablation Catheter and CableBoston Scientific Corp · PMA 2020
- Livewire Tc Ablation Catheter, Safire Ablation CatheterSt Jude Medical · PMA 2016
- Chilli Cooled Ablation SystemBoston Scientific Corp · PMA 2011
- Blazer II Cardiac Ablation System and CableBoston Scientific Corp · PMA 2025
- Freezor Cardiac Cryoablation CatheterMedtronic Cryocath, LP · PMA 2022
- Biosense Webster CablesBiosense Webster, Inc. · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.